時代新材(600458.SH):擬申請註冊發行新一期總額不超15億元超短期融資券
格隆匯3月30日丨時代新材(600458.SH)公佈,公司第八屆董事會第二十次會議審議通過關於公司申請註冊及發行超短期融資券的議案,因公司在中國銀行間債券市場註冊金額為15億元的超短期融資券發行資格將於2020年6月7日到期,公司擬向中國銀行間債券市場交易商協會申請註冊發行新一期總額不超過人民幣15億元(含15億元)超短期融資券,並根據公司資金需求和市場條件,在中國銀行間市場交易商協會註冊有效期(兩年)內分期滾動發行,確保到期償還。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.